Olutasidenib

Name: Olutasidenib
Availability: olutasidenib-357351.html

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Olutasidenib
CAS No.:1887014-12-1
Standard:In-house Standards
Price(USD):Negotiable
Company:Shenzhen Haorui Pharmatech Co., Ltd.

Send Inquiry

Favorites

Similar Products

5-FAM

Empagliflozin

Griseofulvin

99% up GMP DMF Cefoperazone sodium 62893-20-3

Ciprofloxacin other active pharmaceutical ingredients

5-Aza-2'-deoxycytidine

Reverse Phase Silica Gel-C18

AMANTADINEHCL

Artemether

Letrozole

Basic Info

Grade: Pharmaceutical Grade

Factory Location: Hubei

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no

Payment Terms: L/C

Olutasidenib (FT-2102) is a selective and potent isocitrate dehydrogenase-1 (IDH1) inhibitor approved by the FDA in December 2022. It is indicated for the treatment of relapsed or refractory acute myeloid leukemia (AML) in patients with a susceptible IDH1 mutation as determined by an FDA-approved test.

Send your message to this supplier

From:
To:
Shenzhen Haorui Pharmatech Co., Ltd.
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification:

Other Products from this supplier
More>>

Granisetron Hydrochloride

Dasatinib monohydrate

Flumazenil

Docetaxel anhydrous

Epinastine Hydrochloride

Desvenlafaxine succinate

Neostigmine Methylsulfate

Venlafaxine hydrochloride

Vancomycin Hydrochloride

Daptomycin

Olutasidenib

Other Products from this supplierMore>>

Other Products from this supplier
More>>